FGF2 and neoplasm: Typically, E-cadherin protein-expressed recombinant OVs can attenuate antiviral immunity [50], and fibroblast growth factor 2 (FGF2)-expressed OVs was validated to potentiate the sensitivity of tumor cells toward OVs and promote oncolysis effect [51].